11/14/2024
2:05 PM | Cormorant Asset Management, LP (Filed by)
Tarsus Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/13/2024
3:06 PM | Tarsus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
3:40 PM | Lin Elizabeth Yeu (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2024
9:26 AM | Frazier Life Sciences IX, L.P. (Filed by)
Tarsus Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/05/2024
3:06 PM | Tarsus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
1:00 PM | Tarsus Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/21/2024
3:11 PM | BlackRock, Inc. (Filed by)
Tarsus Pharmaceuticals (Subject)
| Form SC 13G/A | |
|
10/02/2024
4:27 PM | Morrison Scott W (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
4:52 PM | Morrison Scott W (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
3:34 PM | LINK WILLIAM J PHD (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
5:21 PM | Tarsus Pharmaceuticals (Issuer)
YARNO WENDY L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
5:22 PM | CHAUDHURI BHASKAR (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
5:23 PM | Morrison Scott W (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
5:24 PM | Lin Elizabeth Yeu (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
5:25 PM | LINK WILLIAM J PHD (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
5:26 PM | Goldberg Andrew D. (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
5:26 PM | Crane Rosemary A (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
3:26 PM | Tarsus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2024
4:44 PM | CHAUDHURI BHASKAR (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
4:45 PM | Goldberg Andrew D. (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
4:33 PM | Lin Elizabeth Yeu (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
4:38 PM | Tarsus Pharmaceuticals (Issuer)
YARNO WENDY L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
4:40 PM | Crane Rosemary A (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
4:28 PM | LINK WILLIAM J PHD (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
4:30 PM | Morrison Scott W (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2024
3:12 PM | Tarsus Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/26/2024
3:24 PM | Tarsus Pharmaceuticals (Filer)
| Form DEF 14A | |
04/26/2024
3:25 PM | Tarsus Pharmaceuticals (Filer)
| Form DEFA14A | |
04/23/2024
7:34 AM | Tarsus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2024
1:56 PM | Tarsus Pharmaceuticals (Subject)
Trevejo Jose M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/28/2024
1:06 PM | Tarsus Pharmaceuticals (Subject)
Trevejo Jose M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/19/2024
6:03 PM | Neervannan Seshadri (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
6:04 PM | Tarsus Pharmaceuticals (Issuer)
Whitfield Dianne C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
6:05 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
6:05 PM | Tarsus Pharmaceuticals (Issuer)
Wahl Bryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
6:08 PM | Mottiwala Aziz (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
2:44 PM | Mottiwala Aziz (Reporting)
Tarsus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/18/2024
2:44 PM | Neervannan Seshadri (Reporting)
Tarsus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/18/2024
2:47 PM | Tarsus Pharmaceuticals (Subject)
Wahl Bryan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
4:57 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
4:45 PM | Tarsus Pharmaceuticals (Issuer)
Wahl Bryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
2024's Must-Watch Stocks! (Ad) Welcome to a year of unparalleled opportunities! Dive into our exclusive guide, "9 Stocks Set to Soar," meticulously selected to elevate your portfolio in 2024. Step into 2024 with confidence and the right assets at your fingertips. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.  [Unlock Your Report Now] |
03/11/2024
4:10 PM | Neervannan Seshadri (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
4:11 PM | Farrow Jeffrey S (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
4:12 PM | Tarsus Pharmaceuticals (Issuer)
Whitfield Dianne C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
4:12 PM | Mottiwala Aziz (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:26 PM | Tarsus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/01/2024
4:17 PM | Tarsus Pharmaceuticals (Filer)
| Form 424B5 | |
02/29/2024
4:08 PM | Tarsus Pharmaceuticals (Filer)
| Form 424B5 | |
02/29/2024
3:32 PM | Tarsus Pharmaceuticals (Filer)
| Form S-3ASR | |
02/27/2024
3:22 PM | Tarsus Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/26/2024
8:18 PM | Tarsus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
6:28 AM | RTW INVESTMENTS, LP (Filed by)
Tarsus Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/09/2024
9:06 AM | MORGAN STANLEY (Filed by)
Tarsus Pharmaceuticals (Subject)
| Form SC 13G | |
02/02/2024
11:40 AM | Cowen Financial Products LLC (Filed by)
Tarsus Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/02/2024
5:05 AM | Tarsus Pharmaceuticals (Subject)
TimesSquare Capital Management, LLC (Filed by)
| Form SC 13G/A | |
01/22/2024
4:05 PM | Paradigm Biocapital Advisors LP (Filed by)
Tarsus Pharmaceuticals (Subject)
| Form SC 13G | |
01/18/2024
3:30 PM | Tarsus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
8:00 AM | Tarsus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/29/2023
4:08 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2023
3:23 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/22/2023
4:30 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2023
4:32 PM | Tarsus Pharmaceuticals (Issuer)
Trevejo Jose M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
3:49 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/20/2023
2:17 PM | Tarsus Pharmaceuticals (Subject)
Trevejo Jose M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/19/2023
5:30 PM | Goldberg Andrew D. (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2023
8:01 AM | Tarsus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2023
5:27 PM | Tarsus Pharmaceuticals (Issuer)
YARNO WENDY L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/01/2023
3:55 PM | Tarsus Pharmaceuticals (Issuer)
Wahl Bryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/01/2023
3:58 PM | Tarsus Pharmaceuticals (Issuer)
Whitfield Dianne C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2023
3:35 PM | Tarsus Pharmaceuticals (Subject)
Whitfield Dianne C. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/21/2023
11:15 PM | Tarsus Pharmaceuticals (Filer)
| Form EFFECT | |
11/17/2023
3:50 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
